These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26907493)

  • 21. Endocytic Pathways Used by Andes Virus to Enter Primary Human Lung Endothelial Cells.
    Chiang CF; Flint M; Lin JS; Spiropoulou CF
    PLoS One; 2016; 11(10):e0164768. PubMed ID: 27780263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunocytochemical and Ultrastructural Evidence Supporting That Andes Hantavirus (ANDV) Is Transmitted Person-to-Person Through the Respiratory and/or Salivary Pathways.
    Pizarro E; Navarrete M; Mendez C; Zaror L; Mansilla C; Tapia M; Carrasco C; Salazar P; Murua R; Padula P; Otth C; Rodríguez EM
    Front Microbiol; 2019; 10():2992. PubMed ID: 31998273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of transcriptional responses between pathogenic and nonpathogenic hantavirus infections in Syrian hamsters using NanoString.
    Brocato RL; Altamura LA; Carey BD; Perley CC; Blancett CD; Minogue TD; Hooper JW
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009592. PubMed ID: 34339406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The adaptive immune response does not influence hantavirus disease or persistence in the Syrian hamster.
    Prescott J; Safronetz D; Haddock E; Robertson S; Scott D; Feldmann H
    Immunology; 2013 Oct; 140(2):168-78. PubMed ID: 23600567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Host mTORC1 signaling regulates andes virus replication.
    McNulty S; Flint M; Nichol ST; Spiropoulou CF
    J Virol; 2013 Jan; 87(2):912-22. PubMed ID: 23135723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of Andes virus entry and neutralization using a pseudovirion system.
    Ray N; Whidby J; Stewart S; Hooper JW; Bertolotti-Ciarlet A
    J Virol Methods; 2010 Feb; 163(2):416-23. PubMed ID: 19903496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Andes Orthohantavirus NSs Protein Antagonizes the Type I Interferon Response by Inhibiting MAVS Signaling.
    Vera-Otarola J; Solis L; Lowy F; Olguín V; Angulo J; Pino K; Tischler ND; Otth C; Padula P; López-Lastra M
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune serum produced by DNA vaccination protects hamsters against lethal respiratory challenge with Andes virus.
    Hooper JW; Ferro AM; Wahl-Jensen V
    J Virol; 2008 Feb; 82(3):1332-8. PubMed ID: 18032485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Truncated hantavirus nucleocapsid proteins for serotyping Sin Nombre, Andes, and Laguna Negra hantavirus infections in humans and rodents.
    Koma T; Yoshimatsu K; Pini N; Safronetz D; Taruishi M; Levis S; Endo R; Shimizu K; Yasuda SP; Ebihara H; Feldmann H; Enria D; Arikawa J
    J Clin Microbiol; 2010 May; 48(5):1635-42. PubMed ID: 20335425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infection of human monocyte-derived dendritic cells by ANDES Hantavirus enhances pro-inflammatory state, the secretion of active MMP-9 and indirectly enhances endothelial permeability.
    Marsac D; García S; Fournet A; Aguirre A; Pino K; Ferres M; Kalergis AM; Lopez-Lastra M; Veas F
    Virol J; 2011 May; 8():223. PubMed ID: 21569520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential pathogenesis between Andes virus strains CHI-7913 and Chile-9717869in Syrian Hamsters.
    Warner BM; Sloan A; Deschambault Y; Dowhanik S; Tierney K; Audet J; Liu G; Stein DR; Lung O; Buchanan C; Sroga P; Griffin BD; Siragam V; Frost KL; Booth S; Banadyga L; Saturday G; Scott D; Kobasa D; Safronetz D
    J Virol; 2021 Apr; 95(10):. PubMed ID: 33627395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First human isolate of Hantavirus (Andes virus) in the Americas.
    Galeno H; Mora J; Villagra E; Fernandez J; Hernandez J; Mertz GJ; Ramirez E
    Emerg Infect Dis; 2002 Jul; 8(7):657-61. PubMed ID: 12095430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An innate immunity-regulating virulence determinant is uniquely encoded by the Andes virus nucleocapsid protein.
    Cimica V; Dalrymple NA; Roth E; Nasonov A; Mackow ER
    mBio; 2014 Feb; 5(1):. PubMed ID: 24549848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal analysis of Andes virus and Sin Nombre virus infections of Syrian hamsters.
    Wahl-Jensen V; Chapman J; Asher L; Fisher R; Zimmerman M; Larsen T; Hooper JW
    J Virol; 2007 Jul; 81(14):7449-62. PubMed ID: 17475651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A hantavirus pulmonary syndrome (HPS) DNA vaccine delivered using a spring-powered jet injector elicits a potent neutralizing antibody response in rabbits and nonhuman primates.
    Kwilas S; Kishimori JM; Josleyn M; Jerke K; Ballantyne J; Royals M; Hooper JW
    Curr Gene Ther; 2014; 14(3):200-10. PubMed ID: 24867065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viral shedding and viraemia of Andes virus during acute hantavirus infection: a prospective study.
    Ferrés M; Martínez-Valdebenito C; Henriquez C; Marco C; Angulo J; Barrera A; Palma C; Barriga Pinto G; Cuiza A; Ferreira L; Rioseco ML; Calvo M; Fritz R; Bravo S; Bruhn A; Graf J; Llancaqueo A; Rivera G; Cerda C; Tischler N; Valdivieso F; Vial P; Mertz G; Vial C; Le Corre N
    Lancet Infect Dis; 2024 Jul; 24(7):775-782. PubMed ID: 38582089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two recombinant human monoclonal antibodies that protect against lethal Andes hantavirus infection in vivo.
    Garrido JL; Prescott J; Calvo M; Bravo F; Alvarez R; Salas A; Riquelme R; Rioseco ML; Williamson BN; Haddock E; Feldmann H; Barria MI
    Sci Transl Med; 2018 Nov; 10(468):. PubMed ID: 30463919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of VSV Pseudovirus and Focus Reduction Neutralization Assays for Measurement of Anti-
    Vial C; Whitaker A; Wilhelm J; Ovalle J; Perez R; Valdivieso F; Ferres M; Martinez-Valdebenito C; Eisenhauer P; Mertz GJ; Hooper JW; Botten JW; Vial PA
    Front Cell Infect Microbiol; 2020; 10():444. PubMed ID: 33042854
    [No Abstract]   [Full Text] [Related]  

  • 39. Antiviral efficacy of favipiravir against two prominent etiological agents of hantavirus pulmonary syndrome.
    Safronetz D; Falzarano D; Scott DP; Furuta Y; Feldmann H; Gowen BB
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4673-80. PubMed ID: 23856782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hantavirus pulmonary syndrome.
    Macneil A; Nichol ST; Spiropoulou CF
    Virus Res; 2011 Dec; 162(1-2):138-47. PubMed ID: 21945215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.